Enhancement of Anti-tumor Immunity by Administration of Macrolepiota procera Extracts |
Han, Kyung-Hoon
(Division of Clinical Research, Medical Institute, Seoul Medical Center)
Kim, Doh-Hee (Division of Clinical Research, Medical Institute, Seoul Medical Center) Song, Kwan-Yong (Division of Clinical Research, Medical Institute, Seoul Medical Center) Lee, Kye-Heui (Division of Clinical Research, Medical Institute, Seoul Medical Center) Kang, Tae-Bong (Department of Biotechnology, Konkuk University) Yoon, Taek-Joon (Department of Food & Nutrition, Yuhan University) |
1 | Emens, L. A. (2006) Roadmap to a better therapeutic tumor vaccine. Int Rev Immunol. 25: 415-443. DOI ScienceOn |
2 | Burnet, F. M. (1970) The concept of immunological surveillance. Prog. Exp. Tumor Res. 13: 1-27. |
3 | Rosenberg, S. A., Yang, J. C. and Restifo, N. P. (2004) Cancer immunotherapy: moving beyond current vaccines. Nat. Med. 10: 909-915. DOI ScienceOn |
4 | Gough, M. J., Melcher, A. A., Ahmed, A., Crittenden, M. R., Riddle, D. S., Linardakis, E., Ruchatz, A. N., Emiliusen, L. M. and Vile, R. G. (2001) Macrophages orchestrate the immune response to tumor cell death. Cancer Res. 61(19): 7240-7247. |
5 | Schnurr, M., Scholz, C., Rothenfusser, S., Galambos, P., Dauer, M., Robe, J., Endres, S. and Eigler, A. (2002) Apoptotic pancreatic tumor cells are superior to cell lysates in promoting cross-priming of cytotoxic T cells and activate NK and gammadelta T cells. Cancer Res. 62: 2347-2352. |
6 | Strome, S. E., Voss, S., Wilcox, R., Wakefield, T. L., Tamada, K., Flies, D., Chapoval, A., Lu, J., Kasperbauer, J. L., Padley, D., Vile, R., Gastineau, D., Wettstein, P. and Chen, L. (2002) Strategies for antigen loading of dendritic cells to enhance the antitumor immune response. Cancer Res. 62: 1884-1889. |
7 | Wolfers, J., Lozier, A., Raposo, G., Regnault, A., Thery, C., Masurier, C., Flament, C., Pouzieux, S., Faure, F., Tursz, T., Angevin, E., Amigorena, S. and Zitvogel, L. (2001) Tumorderived exosomes are a source of shared tumor rejection antigens for CTL cross-priming. Nat. Med. 7: 297-303. DOI ScienceOn |
8 | Ahmad, M., Rees, R. C. and Ali, S. A. (2004) Escape from immunotherapy: possible mechanisms that influence tumor regression/progression. Cancer Immunol. Immunother. 53: 844-854. |
9 | Ha, E. S., Hwang, S. H., Shin, K. S., Yu, K. W., Lee, K. H., Choi, J. S., Park, W. M. and Yoon T. J. (2004) Anti-metastatic activity of glycoprotein fractionated from Acanthopanax senticosus, involvement of NK-cell and macrophage activation. Arch. Pharm. Res. 27: 217-224. DOI ScienceOn |
10 | Zhang, S., Li, W., Xia, Z. and Mao, Y. (2011) CD4 T cell dependent tumor immunity stimulated by dendritic cell based vaccine. Biochem. Biophys. Res. Commun. 413: 294-298. DOI ScienceOn |
11 | Fields, R. C., Shimizu, K. and Mule, J. J. (1998) Murine dendritic cells pulsed with whole tumor lysates mediate potent antitumor immune responses in vitro and in vivo. Proc. Natl. Acad. Sci. USA 95: 9482-9487. DOI ScienceOn |
12 | Nouri-Shirazi, M., Banchereau, J., Bell, D., Burkeholder, S., Kraus, E. T , Davoust, J. and Palucka, K. A. (2000) Dendritic cells capture killed tumor cells and present their antigens to elicit tumor-specific immune responses. J. Immunol. 165: 3797-803. |
13 | Pandolfi, F., Cianci, R., Lolli, S. and Dunn, I.S., Newton, E. E., Haggerty, T.J., Boyl,e L.A. and Kurnick, J. T. (2008) Strategies to overcome obstacles to successful immunotherapy of melanoma. Int. J. Immunopathol. Pharmacol. 21: 493-500 |
14 | Song, S., Zhang, K., You, H., Wang, J., Wang, Z., Yan, C. and Liu, F. (2010) Significant anti-tumour activity of adoptively transferred T cells elicited by intratumoral dendritic cell vaccine injection through enhancing the ratio of CD8(+) T cell/ regulatory T cells in tumour. Clin. Exp. Immunol. 162: 75-83. DOI ScienceOn |
15 | Ogino, T., Bandoh, N., Hayashi, T., Miyokawa, N., Harabuchi, Y. and Ferrone, S. (2003) Association of tapasin and HLA class I antigen down-regulation in primary maxillary sinus squamous cell carcinoma lesions with reduced survival of patients. Clin. Cancer Res. 9: 4043-4051. |
16 | Prasad, S. J., Farrand, K. J., Matthews, S. A., Chang, J. H., McHugh, R. S. and Ronchese, F. (2005) Dendritic cells loaded with stressed tumor cells elicit long-lasting protective tumor immunity in mice depleted of regulatory T cells. J. Immunol. 174: 90-98. |
17 | Witham, T. F., Villa, L., Yang, T., Pollack, I. F., Okada, H., Robbins, P. D. and Chambers, W. H. (2003) Expression of a soluble transforming growth factor-beta (TGFbeta) receptor reduces tumorigenicity by regulating natural killer (NK) cell activity against 9L gliosarcoma in vivo. J. Neurooncol. 64: 63-69. |
18 | Cheuk, A. T., Chan, L., Czepulkowski, B., Berger, S. A., Yagita, H., Okumura, K., Farzaneh, F., Mufti, G. J. and Guinn, B. A. (2006) Development of a whole cell vaccine for acute myeloid leukaemia. Cancer Immunol. Immunother. 55: 68-75. DOI ScienceOn |
19 | Copier, J. and Dalgleish, A. (2006) Overview of tumor cellbased vaccines. Int. Rev. Immunol. 25: 297-319. DOI ScienceOn |
20 | Korbelik, M. and Sun, J. (2006) Photodynamic therapy-generated vaccine for cancer therapy. Cancer Immunol. Immunother. 55: 900-909. DOI ScienceOn |
21 | Yoon, T. J., Kim, J. Y., Kim, H., Hong, C., Lee, H., Lee, C. K., Lee, K. H., Hong, S. and Park, S. H. (2008) Anti-tumor immunostimulatory effect of heat-killed tumor cells. Exp. Mol. Med. 40: 130-144. DOI ScienceOn |
22 | Berzofsky, J. A., Terabe, M., Oh, S., Belyakov, I. M., Ahlers, J. D., Janik, J. E. and Morris, J. C. (2004) Progress on new vaccine strategies for the immunotherapy and prevention of cancer. J. Clin. Invest. 113: 1515-1525. |
23 | Miconnet, I., Koenig, S., Speiser, D., Krieg, A., Guillaume, P., Cerottini, J. C. and Romero, P. (2002) CpG are efficient adjuvants for specific CTL induction against tumor antigenderived peptide. J. Immunol. 168: 1212-1218. |
24 | Seliger, B. (2005) Strategies of tumor immune evasion. Bio- Drugs 19: 347-354. |
25 | Kim, H. J. and Lee, I. S. (2004) Antimutagenic and cytotoxic effects of Korean wild mushrooms extracts. Korean J. Food Sci. Technol. 36: 662-668. |
26 | Barros, L., Baptista, P., Correia, D. M., Morais, J. S. and Ferreira, I. C. (2007) Effects of conservation treatment and cooking on the chemical composition and antioxidant activity of Portuguese wild edible mushrooms. J. Agric. Food Chem. 55: 4781-4788. DOI ScienceOn |
27 | Han, K.H., Kim, D. H., Song, K. Y., Jo, S. Y., Lee, S.W. and Yoon, T. J. (2010) Activation of innate immunity by Lepiota procera enhances antitumor activity. Kor. J. Pharmacogn. 41: 115-121. |
28 | Gutzmer, R., Li, W., Sutterwala, S., Lemos, M. P., Elizalde, J. I., Urtishak, S. L., Behrens, E. M., Rivers, P. M., Schlienger, K., Laufer, T. M., Eck, S. L. and Marks, M. S. (2004) A tumor-associated glycoprotein that blocks MHC class IIdependent antigen presentation by dendritic cells. J. Immunol. 173: 1023-3102. |